Whetstone Capital Advisors LLC Buys Shares of 35,108 Option Care Health, Inc. (NASDAQ:OPCH)

Whetstone Capital Advisors LLC acquired a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 35,108 shares of the company's stock, valued at approximately $815,000. Option Care Health comprises about 0.3% of Whetstone Capital Advisors LLC's portfolio, making the stock its 25th largest position.

A number of other institutional investors have also bought and sold shares of the business. Raymond James Financial Inc. purchased a new stake in Option Care Health in the 4th quarter valued at $2,027,000. Renaissance Technologies LLC boosted its holdings in Option Care Health by 2,032.6% in the 4th quarter. Renaissance Technologies LLC now owns 330,546 shares of the company's stock valued at $7,669,000 after purchasing an additional 315,046 shares during the last quarter. Bank of Nova Scotia purchased a new stake in shares of Option Care Health in the 4th quarter valued at approximately $228,000. Prospector Partners LLC acquired a new stake in shares of Option Care Health during the 4th quarter worth approximately $2,100,000. Finally, Quadrant Capital Group LLC lifted its holdings in Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after acquiring an additional 1,099 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares of the company's stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 0.64% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

Several brokerages have recently commented on OPCH. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Barrington Research upped their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the stock an "outperform" rating in a report on Thursday, February 27th. JPMorgan Chase & Co. upped their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. JMP Securities reiterated a "market outperform" rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Finally, Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and lifted their target price for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $33.00.

Option Care Health Stock Up 0.9 %

NASDAQ OPCH traded up $0.29 on Monday, hitting $31.84. 4,564,946 shares of the stock were exchanged, compared to its average volume of 1,788,693. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The company has a 50-day moving average price of $33.24 and a 200-day moving average price of $28.58. The company has a market cap of $5.23 billion, a PE ratio of 26.76, a PEG ratio of 2.30 and a beta of 1.07. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.